8-K
Current Report
Ultragenyx Pharmaceutical Inc. Filed Acc 0001564590-19-044379
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading rare-8k_20191120.htm…